Granulomatosis with Polyangiitis

Introducing Our 2023-2024 VCRC-VF Fellow: Roger Yang, MD

Roger Yang, MD, began his Vasculitis Clinical Research Consortium (VCRC)-Vasculitis Foundation (VF) Fellowship in September 2022. Dr. Yang’s training through the Penn Vasculitis Center at the University of Pennsylvania will focus on both clinical care of patients with all forms of vasculitis and research on the diseases. As vasculitis may…...

Read more

ABIGAIL QUINN | VF Patient Hero 2022

Granulomatosis with polyangiitis (GPA) • 2021 “I put my armor on, show you how strong how I am, I put my armor on, I’ll show you that I am, I’m unstoppable” — Sia in the song “Unstoppable”...

Read more

ANN MARIE NIZIOLEK | VF Patient Hero 2022

Granulomatosis with polyangiitis (GPA) • 2015 "God didn’t promise days without pain, laughter without sorrow or sunshine without rain. But He did promise strength for the day and light for the way."...

Read more

Amgen Successfully Completes Acquisition of ChemoCentryx

TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., (Oct. 20, 2022) – Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat…...

Read more

MICHAEL AGATHIS | VF Patient Hero 2022

Granulomatosis withpolyangiitis (GPA) • 2013 "Strength comes from true belief and faith in God and the strength to live from my wife and daughters."...

Read more